The University of Queensland

Effect of Passive Immunization on the Progression of Mild Alzheimer's Disease: Solanezumab (LY2062430) versus Placebo (2013–2015)

Grant type:

Eli Lilly Australia Pty Ltd

Researchers:

• 

  Professor Gerard Byrne

  Mayne Professor of Psychiatry
  

  Medical School (Office & AME)

  Faculty of Medicine

Funded by:

Eli Lilly Australia Pty Limited